A network meta-analysis of everolimus plus exemestane versus chemotherapy in the first- and second-line treatment of estrogen receptor-positive metastatic breast cancer
Crossref DOI link: https://doi.org/10.1007/s10549-015-3453-9
Published Online: 2015-06-05
Published Print: 2015-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Generali, Daniele
Venturini, Sergio
Rognoni, Carla
Ciani, Oriana
Pusztai, Lajos
Loi, Sherene
Jerusalem, Guy
Bottini, Alberto
Tarricone, Rosanna
Text and Data Mining valid from 2015-06-05